Geopolitics Alpha

8-K - Axsome Therapeutics, Inc. (0001579428) (Filer)

Published . Updated .

GEOPOLITICS ALPHA8-K - Axsome Therapeutics, Inc.(0001579428) (Filer)AXSMGEOPOLITICS ALPHA

8-K - Axsome Therapeutics filed an 8-K with the SEC on Nov 2 (a notice of a material company event).

Directly affected

  • AXSM Axsome Therapeutics-7.1% 10d

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that Axsome Therapeutics belongs to, so it often moves with news about it.

  • LLY Eli Lilly and+21.6% 30d

    Eli Lilly and is a peer of Axsome Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • JNJ Johnson & Johnson+1.5% 30d

    Johnson & Johnson is a peer of Axsome Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • ABBV AbbVie+11.4% 30d

    AbbVie is a peer of Axsome Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • MRK Merck+3.2% 18d

    Merck is a peer of Axsome Therapeutics in pharmaceutical preparations; rivals often move on the same news.

  • ABT Abbott Laboratories+3.1% 30d

    Abbott Laboratories is a peer of Axsome Therapeutics in pharmaceutical preparations; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
AXSM-0.46%-0.74%baseafter closeafter closeafter closeafter close
XLVNo price data for this ticker———————
LLYNo price data for this ticker———————
JNJNo price data for this ticker———————
ABBVNo price data for this ticker———————
MRKNo price data for this ticker———————
ABTNo price data for this ticker———————

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Filed: 2026-11-02 AccNo: 0001193125-26-442628 Size: 21 MB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Source: sec-edgar

Axsome Therapeutics (AXSM) since this story, compared with the market

CompanyWhenMoveStatus
Axsome Therapeutics (AXSM)three days earlier-0.74%final price
Axsome Therapeutics (AXSM)five days earlier-0.46%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who is named in “8-K - Axsome Therapeutics, Inc. (0001579428) (Filer)”

Companies mentioned with this story

  • AXSM Axsome Therapeutics

    In “8-K - Axsome Therapeutics, Inc. (0001579428) (Filer),” Axsome Therapeutics (AXSM) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> AXSM

How “8-K - Axsome Therapeutics, Inc. (0001579428) (Filer)” reaches Axsome Therapeutics (AXSM)

“8-K - Axsome Therapeutics, Inc. (0001579428) (Filer)” (2 Nov 2026) reaches Axsome Therapeutics (AXSM) through this story.

What ties Axsome Therapeutics (AXSM) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> AXSM

Price levels for Axsome Therapeutics (AXSM)

AXSM traded between 131.60 and 164.65 across 10 sessions. The latest close on file is 144.76.

How solid “8-K - Axsome Therapeutics, Inc. (0001579428) (Filer)” looks

14 out of 100

“8-K - Axsome Therapeutics, Inc. (0001579428) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.